American Society of Gene Therapy--second annual meeting. 9-13 June 1999, Washington DC, USA.

Integrating viral vectors and new strategies for gene therapy were two of the major themes of this annual conference which was attended by over 2000 delegates. The conference was aimed at research scientists of all levels and participation was encouraged from graduate and professor alike. The conference was divided up into educational sessions, providing a review of topics and FDA legislation, scientific symposia concentrating on academic and mechanistic subjects, poster discussions, meet the investigator breakfast sessions and corporate symposia. A large number of pharmaceutical companies, medical publishers and clinical research organizations were represented in the exhibition hall.